Literature DB >> 12890627

First demonstration of a lack of viral sequence evolution in a nonprogressor, defining replication-incompetent HIV-1 infection.

Bin Wang1, Meriet Mikhail, Wayne B Dyer, John J Zaunders, Anthony D Kelleher, Nitin K Saksena.   

Abstract

It is universally acknowledged that genetic diversity is a hallmark of HIV-1 infection, and it is one of the traits that has considerably hampered the development of an effective vaccine. In a study of full-length HIV-1 genomic sequences (>9 kb), we show unique evidence for complete absence of viral evolution in an individual with truly nonprogressive infection. Gross gene defects were not detected, but the state of replication incompetence was attributed to the presence of stop codons in the structural genes gag p17 and p24 and in pol RT, which emerged as a consequence of G-A hypermutation. These inactivating mutations may have occurred early, soon after infection, during the clonal stage of primary viral replication, since these are the sole archival strains present today. This genetic homogeneity, with <1% variation between strains over an 8-year period, suggests that only limited proviral integration events occurred in this patient. Further study on the antigenic properties of this strain may assist in the development of HIV vaccines and therapeutics.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12890627     DOI: 10.1016/s0042-6822(03)00159-4

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  26 in total

1.  HIV-1 continues to replicate and evolve in patients with natural control of HIV infection.

Authors:  Helene Mens; Mary Kearney; Ann Wiegand; Wei Shao; Kristian Schønning; Jan Gerstoft; Niels Obel; Frank Maldarelli; John W Mellors; Thomas Benfield; John M Coffin
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Control of HIV-1 in elite suppressors despite ongoing replication and evolution in plasma virus.

Authors:  Karen A O'Connell; Timothy P Brennan; Justin R Bailey; Stuart C Ray; Robert F Siliciano; Joel N Blankson
Journal:  J Virol       Date:  2010-05-05       Impact factor: 5.103

3.  Broadly cross-neutralizing antibodies in HIV-1 patients with undetectable viremia.

Authors:  M Medina-Ramírez; V Sánchez-Merino; S Sánchez-Palomino; A Merino-Mansilla; C B Ferreira; I Pérez; N González; A Alvarez; J M Alcocer-González; F García; J M Gatell; J Alcamí; E Yuste
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

4.  The degree of HIV-1 amino acid variability is strictly related to different disease progression rates.

Authors:  Rossana Scutari; Monica Faieta; Roberta D'Arrigo; Lavinia Fabeni; Cristina Mussini; Andrea Cossarizza; Claudio Casoli; Carlo Federico Perno; Valentina Svicher; Claudia Alteri; Stefano Aquaro
Journal:  Virus Genes       Date:  2018-05-17       Impact factor: 2.332

5.  Coreceptor usage, diversity, and divergence in drug-naive and drug-exposed individuals from Malawi, infected with HIV-1 subtype C for more than 20 years.

Authors:  Ishla Seager; Simon A Travers; Michael D Leeson; Amelia C Crampin; Neil French; Judith R Glynn; Grace P McCormack
Journal:  AIDS Res Hum Retroviruses       Date:  2014-07-29       Impact factor: 2.205

6.  Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy.

Authors:  Justin R Bailey; Kara G Lassen; Hung-Chih Yang; Thomas C Quinn; Stuart C Ray; Joel N Blankson; Robert F Siliciano
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

7.  CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.

Authors:  Catherine K Koofhethile; Zaza M Ndhlovu; Christina Thobakgale-Tshabalala; Julia G Prado; Nasreen Ismail; Zenele Mncube; Lungile Mkhize; Mary van der Stok; Nonhlanhla Yende; Bruce D Walker; Philip J R Goulder; Thumbi Ndung'u
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

8.  Conserved footprints of APOBEC3G on Hypermutated human immunodeficiency virus type 1 and human endogenous retrovirus HERV-K(HML2) sequences.

Authors:  Andrew E Armitage; Aris Katzourakis; Tulio de Oliveira; John J Welch; Robert Belshaw; Kate N Bishop; Beatrice Kramer; Andrew J McMichael; Andrew Rambaut; Astrid K N Iversen
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

9.  A classification approach for genotyping viral sequences based on multidimensional scaling and linear discriminant analysis.

Authors:  Jiwoong Kim; Yongju Ahn; Kichan Lee; Sung Hee Park; Sangsoo Kim
Journal:  BMC Bioinformatics       Date:  2010-08-21       Impact factor: 3.169

10.  Meta-analysis to test the association of HIV-1 nef amino acid differences and deletions with disease progression.

Authors:  Ravindra Pushker; Jean-Marc Jacqué; Denis C Shields
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.